Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-01 Purchase | 2023-03-02 4:27 pm | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 2,500 | $22.73 | $56,816 | 19,779 (Indirect Direct) | View |
| 2023-01-05 Purchase | 2023-01-09 11:51 am | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 2,500 | $24.96 | $62,396 | 17,279 (Indirect Direct) | View |
| 2023-01-03 Purchase | 2023-01-05 5:00 pm | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 5,000 | $25.43 | $127,129 | 14,779 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 12:18 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 24,000 | $0 | 49,806 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 4:08 pm | 2025-05-16 2034-05-16 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 5,228 | $0 | 5,228 (Direct) | View |
| 2023-09-08 Disposition | 2023-09-08 4:00 pm | N/A N/A | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 159,089 | $0 | 0 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:02 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 933,317 | $0 | 933,317 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-24 2:33 pm | 2024-05-22 2033-05-21 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 18,081 | $0 | 37,860 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-19 4:06 pm | 2024-05-18 2033-05-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 3,454 | $0 | 3,454 (Direct) | View |
| 2022-08-22 Option Award | 2022-08-24 4:08 pm | N/A 2032-08-22 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 4,456 | $0 | 4,456 (Direct) | View |
Ownership | 2022-08-24 4:07 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 0 | $0 | 2,000 (Indirect) | View |
| 2022-07-01 Option Award | 2022-07-01 5:01 pm | 2023-07-01 2032-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 737,050 | $0 | 737,050 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 8:00 pm | N/A 2032-06-08 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2022-05-23 Option Award | 2022-05-25 6:09 pm | 2023-05-23 2032-05-22 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 19,215 | $0 | 22,589 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:01 pm | 2022-07-01 2031-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 474,385 | $0 | 474,385 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 4:30 pm | N/A 2031-06-08 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 17,700 | $0 | 17,700 (Direct) | View |
| 2021-05-21 Option Award | 2021-05-25 4:48 pm | 2022-05-21 2031-05-20 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 10,122 | $0 | 10,122 (Direct) | View |
| 2020-07-10 Option Award(A) | 2020-10-13 7:16 pm | N/A 2030-07-09 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 28,394 | $0 | 28,394 (Direct) | View |
| 2020-07-10 Option Award | 2020-07-14 8:22 pm | N/A 2030-07-10 | Vir Biotechnology Inc. | VIR | Sigal Charles Elliott Director | 57,777 | $0 | 57,777 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-01 5:07 pm | 2021-07-01 2030-07-02 | Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director | 184,258 | $0 | 184,258 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 08:00 am | N/A 2030-06-10 | Surface Oncology Inc. | SURF | Sigal Charles Elliott Director | 12,000 | $0 | 12,000 (Direct) | View |